DDX21 and colorectal carcinoma: In our study, we found miR-218 overexpression in CRC cells to inhibit DDX21 protein expression in HT-29 and HCT116 cell lines; therefore, the loss of miR-218 in CRC could promote CRC progression via the upregulated expression of DDX21.